Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (6)
  • 2025 (77)
  • 2024 (93)
  • 2023 (135)
  • 2022 (150)
  • 2021 (86)
  • 2020 (8)
  • 2019 (3)
  • 2018 (2)
  • 2017 (2)

Subject

  • Drug Trafficking (4103)
  • Synthetic drugs (1097)
  • Guns/Weapons (1009)
  • OCDETF/Task Force (817)
  • Fake Pills (669)
  • Arrests/Convictions - Major (623)
  • Guilty Plea (540)
  • Seizures (Drugs/Property) (473)
  • Prescription Drugs (370)
  • Major Law Enforcement Operation (274)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (235)
  • Pharmaceuticals/Pharmacists/Physicians (226)
  • Money Laundering (207)
  • Gangs (199)
  • Outreach/Drug Prevention (185)
  • Fentanyl Awareness (158)
  • One Pill Can Kill (113)
  • HIDTA (104)
  • Press Conferences (68)
  • Narcoterrorism (54)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (51)
  • Public and Media Affairs - also see Congressional Affairs (51)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Counterfeit Pills (25)
  • Fentanyl Free America (24)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Other (11)
  • Campaigns (10)
  • Intergovernmental Affairs (9)
  • Critical Incident (7)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Overdose (324)
  • Diversion Division (250)

Drug Name

  • Fentanyl (248)
  • Heroin (51)
  • Opioids (50)
  • Oxycodone (47)
  • Cocaine (43)
  • Synthetic Opioids (34)
  • Methamphetamine (29)
  • Hydromorphone (16)
  • Benzodiazepines (9)
  • Morphine (8)
  • Marijuana (Cannabis) (7)
  • Ketamine (5)
  • Ecstasy/MDMA (4)
  • Amphetamines (3)
  • Methadone (3)
  • Steroids (3)
  • K2/Spice (2)
  • Marijuana Concentrates (2)
  • LSD (1)
  • Synthetic Bath Salts or Designer Cathinones (1)
  • Xylazine (1)

Field Division

  • Washington, DC (94)
  • New York (73)
  • New England (37)
  • Seattle (37)
  • San Diego (36)
  • St. Louis (35)
  • Atlanta (33)
  • Chicago (23)
  • Houston (22)
  • Miami (22)
  • Los Angeles (21)
  • El Paso (20)
  • Omaha (17)
  • San Francisco (17)
  • New Jersey (16)
  • Dallas (14)
  • Headquarters (12)
  • New Orleans (11)
  • Louisville (6)
  • Phoenix (6)
  • Rocky Mountain (5)
  • Detroit (3)
  • Philadelphia (2)
Clear All Results
562 Results - Showing 361 to 370
PRESS RELEASE

Minnesota Pharmacist Pleads Guilty to Misappropriating and Adulterating Prescription Pain Medication

MINNEAPOLIS – A Minneapolis woman has pleaded guilty to misappropriating and adulterating prescription morphine while working as a pharmacist. According to court documents, on October 30, 2019, Jennifer Lee Draheim, 42, a pharmacist at Coburn’s Pharmacy in Ramsey, removed a bottle of morphine sulfate from the Scheduled Drug Cabinet and...
PRESS RELEASE

Baltimore Fentanyl Dealer Sentenced to Over Seven Years in Federal Prison for Selling Fentanyl and Other Narcotics to Customers Across Four States

Baltimore, Md., – Yesterday U.S. District Judge Richard D. Bennett sentenced Devin Cunningham, age 27, of Baltimore, to 87 months in federal prison, followed by four years of supervised release, for conspiracy to distribute and possess with intent to distribute controlled substances and possession with intent to distribute controlled substances...
PRESS RELEASE

Oklahoma City Hospital Pays $120,000 to Settle Civil Penalty Claims

OKLAHOMA CITY, OK – INTEGRIS ProHealth, Inc., and its parent, INTEGRIS Health, Inc. (collectively, “INTEGRIS”) paid $120,000 to settle civil penalty claims stemming from allegations that Integris Baptist Medical Center Pharmacy (“Integris Pharmacy”), which is owned and operated by INTEGRIS ProHealth, Inc., violated the Comprehensive Drug Abuse Prevention and Control...
PRESS RELEASE

DEA Miami Field Division Warns of Alarming Increase in Suspected Fentanyl-Related Overdoses in Florida

MIAMI - Today, the Drug Enforcement Administration (DEA) Miami Field Division has issued a Public Safety Alert to warn Florida communities of the increase of mass-overdose events across the state suspected to be related to drug supplies laced with a synthetic opioid. While law enforcement agencies continue to investigate these...
PRESS RELEASE

New Mexico Pharmacy Agrees to Settlement Relating to Violations of the Controlled Substances Act

ALBUQUERQUE, N.M. – Alexander M.M. Uballez, United States Attorney for the District of New Mexico, announced today that Joe’s Pharmacy of Peralta, New Mexico, has agreed to pay to the United States $50,000 representing civil penalties under the Controlled Substances Act (CSA). The agreement settles civil claims against Joe’s Pharmacy...
PRESS RELEASE

Two Day Stretch in Omaha Nets 32,000 Fake Fentanyl Pills

OMAHA, Neb.–Investigators with the Drug Enforcement Administration (DEA) Omaha Division seized approximately 32,000 fake pills in Omaha, some laced with lethal doses of fentanyl, in a two-day span beginning July 8. During the first six months of 2022, DEA investigators seized approximately 151,500 pills in Nebraska, marking an 83 percent...
PRESS RELEASE

San Diego Resident Pleads Guilty to Distributing Fentanyl that Resulted in 15-Year-Old’s Death

SAN DIEGO – Kaylar Junior Tawan Beltranlap of San Diego pleaded guilty today to distributing a fake pill containing fentanyl that killed a 15-year-old Coronado High School sophomore, referred to in court records as C.J.S., on May 12, 2021. During the change of plea hearing, Beltranlap admitted to utilizing his...
PRESS RELEASE

Bonifay Doctor Settles Controlled Substances Act Violations For $130,000

PENSACOLA, Fla. —Ahmad T. Ismail, 70, of Bonifay, Florida, settled potential violations of the Controlled Substances Act by agreeing to pay a fine of $130,000 and surrendering his Drug Enforcement Administration (DEA) registration. The settlement was announced by Jason R. Coody, United States Attorney for the Northern District of Florida...
PRESS RELEASE

Fentanyl Overdose Death behind Federal Charges in Drug Case

ST. LOUIS – A man from St. Louis County is facing a federal drug charge after allegedly providing fentanyl to a 19-year-old who then suffered what is suspected to be a fatal overdose. William Edward Martin, 21, was charged by complaint Thursday with one count of distributing a controlled substance...
PRESS RELEASE

Idaho Man Sentenced to 48 Months for Distributing Fentanyl

BOISE, Idaho – On Friday, July 1, 2022, Dakota James Hoffman, 29, of Bellevue, Idaho, was sentenced to 48 months in federal prison for distribution of fentanyl, U.S. Attorney Josh Hurwit announced. According to court records, Hoffman distributed oxycodone pills to a man with the initials A.K. who overdosed on...

Pagination

  • First page «
  • Previous
  • Page 33
  • Page 34
  • Page 35
  • Page 36
  • Current page 37
  • Page 38
  • Page 39
  • Page 40
  • Page 41
  • Next
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster